Work

Abstract PS5-03-18: Clinicopathological features and outcomes of triple-negative breast cancer relapsing after pembrolizumab-based neoadjuvant therapy

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps5-03-18

Authors: R. Kabirian, M. Gendreau, F. C. Bidard, F. Lerebours, A. Vincent Salomon, L. Djerroudi, P. H. Cottu, F. Coussy, J. Y. Pierga, L. Cabel, D. Loirat

Institution: Institut Curie

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130717293

Cites:

Cited by:

Related to: